Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

4.470 -0.030 (-0.67%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cytek Biosciences, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
New System Saves Time and Resources, Improves Efficiency and Accuracy 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Reports Third Quarter 2023 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters
Certification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the United States 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
Company to Lead Symposiums at ICCS and ESCCA 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to Highly Complex Assays 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
Sales Organization Enhanced, Platform Organization Created 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Reports Second Quarter 2023 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Announces $50 Million Stock Repurchase Program
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Reports First Quarter 2023 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Introduces New 20-Color AML Panel
Optimized for Cytek Cell Analysis Systems; Single-Tube Panel Accelerates Acute Myeloid Leukemia Research and MRD Detection 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Participate in Upcoming Investor Conferences
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Introduces Cytek Cloud
New Digital Ecosystem Supports Full Spectrum Flow Cytometry Research – from Panel Design to Data Acquisition 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Reports Third Quarter 2022 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Names Chris Williams Chief Operating Officer
From Cytek Biosciences, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.